Algert Global’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Algert Global’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-33,108	Closed	-$1.13M	–	1665
2024 Q2	$1.13M	Buy	33,108 +16,531	+100%	+$490K	0.04%	654
2024 Q1	$584K	Hold	16,577	–	–	0.02%	741
2023 Q4	$479K	Buy	+16,577	New	+$395K	0.02%	834
2023 Q3	–	Sell	-23,046	Closed	-$1.32M	–	1282
2023 Q2	$1.32M	Sell	23,046 -30,890	-57%	-$1.61M	0.06%	557
2023 Q1	$2.03M	Sell	53,936 -24,542	-31%	-$904K	0.1%	342
2022 Q4	$2.1M	Buy	+78,478	New	+$2.14M	0.12%	280

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

Algert Global's MORF Position: Q3 2024 in Review

Algert Global sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 33,108 shares — an estimated $1.13M sold.

Algert Global first reported a position in MORF in Q4 2022 and held it in 6 quarters. The position peaked at $2.1M in Q4 2022. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

Algert Global reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Algert Global sold 33,108 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $1.13M.
Algert Global first reported a position in Morphic Holding, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
Algert Global's Morphic Holding, Inc. Common Stock position peaked at $2.1M in Q4 2022.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Algert Global's 13F filing for Q3 2024, filed 12 Nov 2024.